Manipal Health Enterprises (MANIPALHOS) Q4 25/26 earnings summary

Executive summary

• FY26 consolidated revenue rose to ₹4,418.81 crore from ₹3,289.30 crore; net profit fell to ₹278.97 crore from ₹439.38 crore.

• Standalone revenue was ₹2,474.30 crore versus ₹2,153.75 crore; net profit declined to ₹205.94 crore from ₹331.22 crore.

• BSR & Co. LLP issued unmodified opinions on FY26 audited standalone and consolidated results.

Financial highlights

• Consolidated Q4 revenue was ₹1,298.43 crore versus ₹843.98 crore YoY; Q4 net profit was ₹13.79 crore versus ₹186.62 crore.

• Consolidated FY26 PBT was ₹339.80 crore versus ₹457.19 crore; finance costs were ₹571.91 crore versus ₹265.96 crore.

• Standalone FY26 PBT was ₹275.30 crore versus ₹445.54 crore; finance costs were ₹422.45 crore versus ₹116.89 crore.

• Consolidated operating cash flow reached ₹759.26 crore versus ₹657.81 crore; investing cash outflow was ₹5,823.43 crore, including subsidiary acquisition.

Segment performance

• Operations comprise one business and geographic segment: healthcare services in India; results are reviewed at entity level standalone and group level consolidated.